Retifanlimab with platinum-based chemotherapy for treating inoperable, locally recurrent or metastatic squamous cell anal canal cancer untreated with systemic chemotherapy [ID6482]

• Awaiting development
• Reference number: GID-TA11625
• Expected publication date: TBC